AMAG Pharmaceuticals, Inc. To Present At Upcoming Investor Conferences

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will provide a brief overview of the company followed by a question and answer period with investors at the following investor conferences during the month of February:
  • February 16, at 9:30 a.m. ET – Leerink Swann 2012 Global Healthcare Conference in New York City; and
  • February 27, at 11:30 a.m. ET – Citi 2012 Global Healthcare Conference in New York City.

A live webcast of each presentation will be accessible through the Investors section of the company’s website at Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website for approximately two weeks.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit

Copyright Business Wire 2010

If you liked this article you might like

Biotech Movers: Luminex, Exelixis, AMAG Pharmaceuticals

Biotech Premarket Movers: Pacific Biosciences of California, AMAG, Global Blood Therapeutics

Today's Perilous Reversal Stock: AMAG Pharmaceuticals (AMAG)

Practice Patience With AMAG Pharma

Practice Patience With AMAG Pharma

Allergan Could Buy These Drug Companies Now That the Pfizer Merger Is Scuttled